These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35316889)

  • 21. [Magnetic resonance tomography in plasmacytoma: ranking of various sequences in diffuse and focal infiltration patterns].
    Baur A; Stäbler A; Steinborn M; Schnarkowski P; Pistitsch C; Lamerz R; Bartl R; Reiser M
    Rofo; 1998 Apr; 168(4):323-9. PubMed ID: 9589093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis.
    Lee SY; Kim HJ; Shin YR; Park HJ; Lee YG; Oh SJ
    Eur Radiol; 2017 Jun; 27(6):2333-2347. PubMed ID: 27595836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-energy CT of the bone marrow in multiple myeloma: diagnostic accuracy for quantitative differentiation of infiltration patterns.
    Kosmala A; Weng AM; Krauss B; Knop S; Bley TA; Petritsch B
    Eur Radiol; 2018 Dec; 28(12):5083-5090. PubMed ID: 29882069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histogram Analysis Based on Apparent Diffusion Coefficient Maps of Bone Marrow in Multiple Myeloma: An Independent Predictor for High-risk Patients Classified by the Revised International Staging System.
    Wang Q; Zhang L; Li S; Sun Z; Wu X; Zhao A; Benkert T; Zhou D; Xue H; Jin Z; Li J
    Acad Radiol; 2022 Jun; 29(6):e98-e107. PubMed ID: 34452820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients.
    Bila J; Jelicic J; Dencic Fekete M; Trajkovic G; Sretenovic A; Perunicic Jovanovic M; Antic D; Mihaljevic B
    Oncol Res Treat; 2017; 40(10):616-620. PubMed ID: 28950269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1/angiopoietin-2 ratio in patients with multiple myeloma.
    Terpos E; Matsaridis D; Koutoulidis V; Zagouri F; Christoulas D; Fontara S; Panourgias E; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Moulopoulos LA
    Ann Hematol; 2017 Oct; 96(10):1707-1714. PubMed ID: 28766001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents.
    Shang Y; Jin Y; Liu H; Ding L; Tong X; Tu H; Zang L; Lin C; Hu J; Zhou F
    Hematol Oncol; 2022 Apr; 40(2):212-222. PubMed ID: 34860428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.
    González-Calle V; Slack A; Keane N; Luft S; Pearce KE; Ketterling RP; Jain T; Chirackal S; Reeder C; Mikhael J; Noel P; Mayo A; Adams RH; Ahmann G; Braggio E; Stewart AK; Bergsagel PL; Van Wier SA; Fonseca R
    Ann Hematol; 2018 Aug; 97(8):1453-1462. PubMed ID: 29623394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical Application of R-ISS Staging System in 412 Newly Diagnosed Patients with Multiple Myeloma].
    Chen HM; Wei W; Peng R; Shi HT; Chen XL; Wu LX; Zhou N; Zhou F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):110-114. PubMed ID: 30738456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma.
    Galieni P; Travaglini F; Vagnoni D; Ruggieri M; Caraffa P; Bigazzi C; Falcioni S; Picardi P; Mazzotta S; Troiani E; Dalsass A; Mestichelli F; Angelini M; Camaioni E; Maravalle D; Angelini S; Pezzoni V
    Br J Haematol; 2021 May; 193(3):542-550. PubMed ID: 33792026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy.
    Paschali A; Panagiotidis E; Triantafyllou T; Palaska V; Tsirou K; Verrou E; Υiannaki E; Markala D; Papanikolaou A; Pouli A; Konstantinidou P; Chatzipavlidou V; Terpos E; Katodritou E
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1487-1497. PubMed ID: 33099659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
    Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
    AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of bone marrow infiltration patterns in multiple myeloma seen on magnetic resonance imaging-Case report and imaging perspective.
    Costachescu D; Ionita H
    Clin Case Rep; 2022 Oct; 10(10):e6452. PubMed ID: 36267826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
    D'Agostino M; Cairns DA; Lahuerta JJ; Wester R; Bertsch U; Waage A; Zamagni E; Mateos MV; Dall'Olio D; van de Donk NWCJ; Jackson G; Rocchi S; Salwender H; Bladé Creixenti J; van der Holt B; Castellani G; Bonello F; Capra A; Mai EK; Dürig J; Gay F; Zweegman S; Cavo M; Kaiser MF; Goldschmidt H; Hernández Rivas JM; Larocca A; Cook G; San-Miguel JF; Boccadoro M; Sonneveld P
    J Clin Oncol; 2022 Oct; 40(29):3406-3418. PubMed ID: 35605179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.
    Zhang L; Wang Q; Wu X; Zhao A; Feng J; Zhang H; Cao X; Li S; Cai H; Sun Z; Duan M; Zhu T; Zhang W; Jin Z; Zhou D; Xue H; Li J
    Eur Radiol; 2021 Apr; 31(4):1843-1852. PubMed ID: 32965573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and
    Cho HJ; Jung SH; Jo JC; Lee YJ; Yoon SE; Park SS; Kim DY; Shin HJ; Mun YC; Yi JH; Kim HJ; Kim DJ; Lee HS; Bae SH; Hong CM; Jeong SY; Min JJ; Sohn SK; Min CK; Kim K; Lee JJ; Moon JH;
    Blood Cancer J; 2021 Dec; 11(12):190. PubMed ID: 34853295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Diffusion-weighted Imaging of the Bone Marrow: An Adjunct Tool for the Diagnosis of a Diffuse MR Imaging Pattern in Patients with Multiple Myeloma.
    Koutoulidis V; Fontara S; Terpos E; Zagouri F; Matsaridis D; Christoulas D; Panourgias E; Kastritis E; Dimopoulos MA; Moulopoulos LA
    Radiology; 2017 Feb; 282(2):484-493. PubMed ID: 27610934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of magnetic resonance imaging findings in transplanted multiple myeloma patients with hip/pelvic pain (according to MY-RADS): A single center experience.
    Rossi F; Torri L; Dominietto A; Tagliafico AS
    Eur J Radiol; 2020 Sep; 130():109154. PubMed ID: 32629214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.